Sofinnova Ventures »

Definium Therape shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.5M 344k 18.90

More positions owned by Sofinnova Ventures

Natera (NTRA)
iShares TR Russell 2000 Etf Put Option (IWM)
United Therapeutics Corporation Put Option (UTHR)
SPDR Series Trust State Street Spd Put Option (XBI)
Bristol Myers Squibb (BMY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Vera Therapeutics Cl A (VERA)
AstraZeneca Ord (AZN)
Invesco QQQ TR Unit Ser 1 Put Option (QQQ)
Cogent Biosciences (COGT)
iShares TR Ishares Biotech Put Option (IBB)
Celcuity (CELC)
Ultragenyx Pharmaceutical (RARE)
Axsome Therapeutics Put Option (AXSM)
Rapport Therapeutics (RAPP)

View all positions for Sofinnova Ventures

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape